HomeNewsBusinessAnnouncementsGlenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol tablets

Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol tablets

Glenmark Generics Inc. USA, a subsidiary of Glenmark Generic has been granted final ANDA from the USFDA for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5mcg and 1 mg/5 mcg. Glenmark will commence distribution of the product immediately.

April 07, 2015 / 09:42 IST
Story continues below Advertisement

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated April 07, 2015, titled "Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1mg/5 mcg.".Source : BSE

Read all announcements in Glenmark

first published: Apr 7, 2015 09:42 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!